beta

GNMX

Aevi Genomic Medicine Inc.

Gnmx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-01-2018 08-02-2018 05-15-2018 03-13-2018 11-02-2017 08-09-2017 05-10-2017
Actual EPS -0.12 -0.14 -0.15 -0.13 -0.23 -0.22 -0.29
Consensus EPS -0.16 -0.15 -0.15 -0.15 -0.24 -0.26 -0.27
Estimated EPS -0.16 -0.15 -0.15 -0.15 -0.24 -0.26 -0.27
Number of Estimates 2 2 2 1 2 3 3
EPS Surprise $0.04 $0.01 $0.02 $0.01 $0.04 -$0.02

Stats

Summary

Aevi Genomic Medicine Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

Market Cap: 104 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.aevigenomics.com

Shares Outstanding: 59.3 Million

Float: 52.2 Million

Dividend: 0.0 (0.0%)

Beta: 1.039158

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 238 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1600 trading days

From: 2015-09-18 To: 2019-06-12

Lowest Point:

Aevi Genomic's AEVI-001 flunks mid-stage ADHD study

via: SeekingAlpha at 2019-01-02 16:46:01:000

A Phase 2 clinical trial, ASCEND, evaluating Aevi Genomic Medicine's (NASDAQ: GNMX ) lead candidate AEVI-001 in children aged 6 - 17 with attention deficit hyperactivity disorder (ADHD) failed to achieve the primary in either Part A or Part B after six weeks of treatment. More news on:… read more...

Aevi Genomic's AEVI-001 flunks mid-stage ADHD study

via: SeekingAlpha at 2019-01-02 16:46:01:000

A Phase 2 clinical trial, ASCEND, evaluating Aevi Genomic Medicine's (NASDAQ: GNMX ) lead candidate AEVI-001 in children aged 6 - 17 with attention deficit hyperactivity disorder (ADHD) failed to achieve the primary in either Part A or Part B after six weeks of treatment. More news on:… read more...

Aevi Genomic's AEVI-001 flunks mid-stage ADHD study

via: SeekingAlpha at 2019-01-02 16:46:01:000

A Phase 2 clinical trial, ASCEND, evaluating Aevi Genomic Medicine's (NASDAQ: GNMX ) lead candidate AEVI-001 in children aged 6 - 17 with attention deficit hyperactivity disorder (ADHD) failed to achieve the primary in either Part A or Part B after six weeks of treatment. More news on:… read more...

Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD

via: PR Newswire at 2019-01-02 16:30:00:000

PHILADELPHIA , Jan. 2, 2019 /PRNewswire/ --Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) ("the Company") today announced that the ASCEND trial, a genomically-guided Phase 2 double-blind, placebo-controlled clinical trial of orally-administered AEVI-001 (100 400 mg BID) in chil… read more...

Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD

via: PR Newswire at 2019-01-02 16:30:00:000

PHILADELPHIA , Jan. 2, 2019 /PRNewswire/ --Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) ("the Company") today announced that the ASCEND trial, a genomically-guided Phase 2 double-blind, placebo-controlled clinical trial of orally-administered AEVI-001 (100 400 mg BID) in chil… read more...

Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD

via: PR Newswire at 2019-01-02 16:30:00:000

PHILADELPHIA , Jan. 2, 2019 /PRNewswire/ --Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) ("the Company") today announced that the ASCEND trial, a genomically-guided Phase 2 double-blind, placebo-controlled clinical trial of orally-administered AEVI-001 (100 400 mg BID) in chil… read more...

Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD

via: PR Newswire at 2018-11-26 08:00:00:000

PHILADELPHIA , Nov. 26, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that the Aevi Genomic Medicine Management team will host a breakfast with Key Opinion Leader (KOL) Robert Findling, M.D., Leonard and Helen R. Stulman Profes… read more...

Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD

via: PR Newswire at 2018-11-26 08:00:00:000

PHILADELPHIA , Nov. 26, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that the Aevi Genomic Medicine Management team will host a breakfast with Key Opinion Leader (KOL) Robert Findling, M.D., Leonard and Helen R. Stulman Profes… read more...

Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD

via: PR Newswire at 2018-11-26 08:00:00:000

PHILADELPHIA , Nov. 26, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that the Aevi Genomic Medicine Management team will host a breakfast with Key Opinion Leader (KOL) Robert Findling, M.D., Leonard and Helen R. Stulman Profes… read more...

Aevi Genomic reports Q3 results

via: SeekingAlpha at 2018-11-01 08:07:30:000

Aevi Genomic (NASDAQ: GNMX ): Q3 GAAP EPS of -$0.12. More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q3 results

via: SeekingAlpha at 2018-11-01 08:07:30:000

Aevi Genomic (NASDAQ: GNMX ): Q3 GAAP EPS of -$0.12. More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q3 results

via: SeekingAlpha at 2018-11-01 08:07:30:000

Aevi Genomic (NASDAQ: GNMX ): Q3 GAAP EPS of -$0.12. More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-11-01 07:30:00:000

PHILADELPHIA , Nov. 1, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended September 30 , 2018and provided an overview of the Company's recent corporate progress. Thir… read more...

Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-11-01 07:30:00:000

PHILADELPHIA , Nov. 1, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended September 30 , 2018and provided an overview of the Company's recent corporate progress. Thir… read more...

Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-11-01 07:30:00:000

PHILADELPHIA , Nov. 1, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended September 30 , 2018and provided an overview of the Company's recent corporate progress. Thir… read more...

Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%

via: SeekingAlpha at 2018-10-15 10:29:26:000

Thinly traded nano cap Aevi Genomic Medicine ( GNMX +1.9% ) is up on below-average volume following its announcement that Part B of its Phase 2 ASCEND study evaluating AEVI-001 in pediatric and adolescent patients with attention deficit hyperactivity disorder (ADHD) is now fully enrolled… read more...

Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%

via: SeekingAlpha at 2018-10-15 10:29:26:000

Thinly traded nano cap Aevi Genomic Medicine ( GNMX +1.9% ) is up on below-average volume following its announcement that Part B of its Phase 2 ASCEND study evaluating AEVI-001 in pediatric and adolescent patients with attention deficit hyperactivity disorder (ADHD) is now fully enrolled… read more...

Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%

via: SeekingAlpha at 2018-10-15 10:29:26:000

Thinly traded nano cap Aevi Genomic Medicine ( GNMX +1.9% ) is up on below-average volume following its announcement that Part B of its Phase 2 ASCEND study evaluating AEVI-001 in pediatric and adolescent patients with attention deficit hyperactivity disorder (ADHD) is now fully enrolled… read more...

Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial

via: PR Newswire at 2018-10-15 08:00:00:000

PHILADELPHIA , Oct. 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has reached full enrollment of Part B of its Phase 2 ASCEND clinical trial. The ASCEND trial is a genomically-guided study in pediatric and adolescent… read more...

Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial

via: PR Newswire at 2018-10-15 08:00:00:000

PHILADELPHIA , Oct. 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has reached full enrollment of Part B of its Phase 2 ASCEND clinical trial. The ASCEND trial is a genomically-guided study in pediatric and adolescent… read more...

Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial

via: PR Newswire at 2018-10-15 08:00:00:000

PHILADELPHIA , Oct. 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has reached full enrollment of Part B of its Phase 2 ASCEND clinical trial. The ASCEND trial is a genomically-guided study in pediatric and adolescent… read more...

Aevi Genomic Medicine (GNMX) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

via: SeekingAlpha at 2018-09-06 14:55:33:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic Medicine (GNMX) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

via: SeekingAlpha at 2018-09-06 14:55:33:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic Medicine (GNMX) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow

via: SeekingAlpha at 2018-09-06 14:55:33:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

FDA rejects Sunovion's dasotraline for ADHD

via: SeekingAlpha at 2018-08-31 09:47:20:000

Privately-held Sunovion Pharmaceuticals has received a CRL from the FDA in response to its marketing application seeking approval for dasotraline, a dual-acting dopamine and norepinephrine reuptake inhibitor, for the treatment of attention deficit hyperactivity disorder (ADHD). More ne… read more...

Aevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment Conference

via: PR Newswire at 2018-08-29 08:00:00:000

PHILADELPHIA , Aug. 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5,… read more...

Aevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment Conference

via: PR Newswire at 2018-08-29 08:00:00:000

PHILADELPHIA , Aug. 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5,… read more...

Daily Insider Ratings Round Up 8/17/18

via: SeekingAlpha at 2018-08-21 12:58:32:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

Daily Insider Ratings Round Up 8/17/18

via: SeekingAlpha at 2018-08-21 12:58:32:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

Daily Insider Ratings Round Up 8/17/18

via: SeekingAlpha at 2018-08-21 12:58:32:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial

via: PR Newswire at 2018-08-21 08:00:00:000

PHILADELPHIA , Aug. 21, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced the sale of 5.1 million shares of its common stock for aggregate proceeds of$4.9 million, before expenses. The sales were through the Company's existing ATM progra… read more...

Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial

via: PR Newswire at 2018-08-21 08:00:00:000

PHILADELPHIA , Aug. 21, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced the sale of 5.1 million shares of its common stock for aggregate proceeds of$4.9 million, before expenses. The sales were through the Company's existing ATM progra… read more...

Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial

via: PR Newswire at 2018-08-21 08:00:00:000

PHILADELPHIA , Aug. 21, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced the sale of 5.1 million shares of its common stock for aggregate proceeds of$4.9 million, before expenses. The sales were through the Company's existing ATM progra… read more...

Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD

via: PR Newswire at 2018-08-14 08:00:00:000

PHILADELPHIA , Aug. 14, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has completed enrollment in Part A (n=64) of its Phase 2 ASCEND clinical trial, which is assessing a mGluR mutation positive genetic subset of pediatric a… read more...

Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD

via: PR Newswire at 2018-08-14 08:00:00:000

PHILADELPHIA , Aug. 14, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has completed enrollment in Part A (n=64) of its Phase 2 ASCEND clinical trial, which is assessing a mGluR mutation positive genetic subset of pediatric a… read more...

Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD

via: PR Newswire at 2018-08-14 08:00:00:000

PHILADELPHIA , Aug. 14, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it has completed enrollment in Part A (n=64) of its Phase 2 ASCEND clinical trial, which is assessing a mGluR mutation positive genetic subset of pediatric a… read more...

Aevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-08-02 07:30:00:000

PHILADELPHIA , Aug. 2, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended June 30 , 2018and provided an overview of the Company's recent corporate progress. Second Qu… read more...

Aevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-08-02 07:30:00:000

PHILADELPHIA , Aug. 2, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended June 30 , 2018and provided an overview of the Company's recent corporate progress. Second Qu… read more...

Aevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-08-02 07:30:00:000

PHILADELPHIA , Aug. 2, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended June 30 , 2018and provided an overview of the Company's recent corporate progress. Second Qu… read more...

Aevi Genomic Medicine announces new co-crystal version of fasoracetam

via: SeekingAlpha at 2018-07-19 09:34:10:000

Aevi Genomic Medicine ( GNMX ) has received positive feedback from the FDA provisionally indicating that AEVI-004 is a novel co-crystal of lead drug AEVI-001 (fasoracetam) with enhanced physical and chemical properties. More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, … read more...

Aevi Genomic Medicine announces new co-crystal version of fasoracetam

via: SeekingAlpha at 2018-07-19 09:34:10:000

Aevi Genomic Medicine ( GNMX ) has received positive feedback from the FDA provisionally indicating that AEVI-004 is a novel co-crystal of lead drug AEVI-001 (fasoracetam) with enhanced physical and chemical properties. More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, … read more...

Aevi Genomic Medicine announces new co-crystal version of fasoracetam

via: SeekingAlpha at 2018-07-19 09:34:10:000

Aevi Genomic Medicine ( GNMX ) has received positive feedback from the FDA provisionally indicating that AEVI-004 is a novel co-crystal of lead drug AEVI-001 (fasoracetam) with enhanced physical and chemical properties. More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, … read more...

Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001

via: PR Newswire at 2018-07-19 08:30:00:000

PHILADELPHIA , July 19, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the Company's lead development m… read more...

Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001

via: PR Newswire at 2018-07-19 08:30:00:000

PHILADELPHIA , July 19, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the Company's lead development m… read more...

Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001

via: PR Newswire at 2018-07-19 08:30:00:000

PHILADELPHIA , July 19, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it received positive feedback from the United States Food and Drug Administration (FDA) on an improved version of the Company's lead development m… read more...

Evaluating KemPharm's KP415, Part 2: The History Of ADHD Treatment And The Competitive Landscape

via: SeekingAlpha at 2018-06-21 16:30:00:000

Introduction Porter's Five Forces analysis , first published in 1979, is a framework for thinking about a product's competitive landscape that I'm sure most investors have heard of, or if not, something they understand intuitively: KemPharm's ( KMPH ) KP415 may soon join a hefty mix of ADHD… read more...

Evaluating KemPharm's KP415, Part 2: The History Of ADHD Treatment And The Competitive Landscape

via: SeekingAlpha at 2018-06-21 16:30:00:000

Introduction Porter's Five Forces analysis , first published in 1979, is a framework for thinking about a product's competitive landscape that I'm sure most investors have heard of, or if not, something they understand intuitively: KemPharm's ( KMPH ) KP415 may soon join a hefty mix of ADHD… read more...

Evaluating KemPharm's KP415, Part 2: The History Of ADHD Treatment And The Competitive Landscape

via: SeekingAlpha at 2018-06-21 16:30:00:000

Introduction Porter's Five Forces analysis , first published in 1979, is a framework for thinking about a product's competitive landscape that I'm sure most investors have heard of, or if not, something they understand intuitively: KemPharm's ( KMPH ) KP415 may soon join a hefty mix of ADHD… read more...

Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference

via: PR Newswire at 2018-06-13 08:00:00:000

PHILADELPHIA , June 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Wednesday, June 20, 2018 at 1:00 … read more...

Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference

via: PR Newswire at 2018-06-13 08:00:00:000

PHILADELPHIA , June 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Wednesday, June 20, 2018 at 1:00 … read more...

Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference

via: PR Newswire at 2018-06-13 08:00:00:000

PHILADELPHIA , June 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Wednesday, June 20, 2018 at 1:00 … read more...

Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD

via: PR Newswire at 2018-06-12 08:00:00:000

PHILADELPHIA , June 12, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) today announced that it will increase the sample size for Part A of its Phase 2 ASCEND clinical trial, which is enrolling a mGluR mutation positive genetic subset of pediatric and … read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference

via: PR Newswire at 2018-05-29 08:00:00:000

PHILADELPHIA , May 29, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 4:30… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic Medicine: Try Subgroups Until It Works?

via: SeekingAlpha at 2018-05-20 10:31:09:000

The History of Aevi Genomic Medicine Aevi Genomic Medicine (GNMX) was founded as Medgenics in 2000 in Israel. It later moved to be based in Wayne, PA. Medgenics went public on April 8, 2011, under the symbol MDGN. In the September of 2015, Medgenics acquired the assets of a company calle… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic down 6% on Q1 result

via: SeekingAlpha at 2018-05-15 09:01:55:000

Aevi Genomic ( GNMX ) Q1 results : Revenues: $0; R&D Expense: $6.6M (-16.5%); SG&A: $2.2M (-26.7%); Net Loss: ($8.7M) (+20.2%); Loss Per Share: ($0.15) (+48.3%); Quick Assets: $26.5M (-21.4%). More news on: Aevi Genomic Medicine, Inc., Healthcare stocks news, Earnings news and com… read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic reports Q1 results

via: SeekingAlpha at 2018-05-15 08:41:55:000

Aevi Genomic (NASDAQ: GNMX ): Q1 EPS of -$0.15 More news on: Aevi Genomic Medicine, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update

via: PR Newswire at 2018-05-15 08:30:00:000

PHILADELPHIA , May 15, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the "Company") announced today financial and operational results for the three months ended March 31 , 2018and provided an overview of the Company's recent corporate progress. First Qu… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX

via: Business Wire at 2018-04-30 09:35:00:000

Levi & Korsinsky announces it has commenced an investigation of Aevi Genomic Medicine, Inc. (NASDAQGM: GNMX) concerning possible breaches of fiduciary duty. To obtain additional information, go to : http://www.zlkdocs.com/GNMX-Info-Request-Form-6655 or contact Joseph E. Levi… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

via: PR Newswire at 2018-04-29 18:56:00:000

NEW YORK , April 29, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX… read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic (GNMX) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow

via: SeekingAlpha at 2018-03-29 13:02:35:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with this Read more … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine to Present at the 17th Annual Needham Healthcare Conference

via: PR Newswire at 2018-03-20 08:00:00:000

PHILADELPHIA , March 20, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine, Inc. 2017 Q4 - Results - Earnings Call Slides

via: SeekingAlpha at 2018-03-14 13:46:04:000

The following slide deck was published by Aevi Genomic Medicine, Inc. in conjunction with their 2017 Q4 earnings Read more … read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine's (GNMX) CEO Mike Cola on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-13 13:40:02:000

Aevi Genomic Medicine, Inc. (GNMX) Q4 2017 Earnings Conference Call March 13, 2018, 08:30 ET Executives Brian Piper Chief Financial Officer Mike Cola - Chief Executive Officer Garry Neil - Chief Scientific Officer Analysts Jason Butler - JMP Securities Chad Messe… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

via: PR Newswire at 2018-03-13 07:30:00:000

PHILADELPHIA , March 13, 2018 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued adv… read more...

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

via: SeekingAlpha at 2018-02-06 11:42:23:000

Welcome to the 76th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril… read more...

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

via: SeekingAlpha at 2018-02-06 11:42:23:000

Welcome to the 76th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril… read more...

ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

via: SeekingAlpha at 2018-02-06 11:42:23:000

Welcome to the 76th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril… read more...

ROTY Edition 1 Volume 58: Increasing Contender Coverage And Trades

via: SeekingAlpha at 2017-12-05 09:40:15:000

Welcome to the 58th entry in our Runner of the Year ((ROTY)) series. Our model account utilizes a full-position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primar… read more...

Aevi Genomic Medicine Announces New Appointment to its Board of Directors

via: PR Newswire at 2017-12-04 16:01:00:000

PHILADELPHIA , Dec. 4, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today the appointment of Matthew D. Bayley , MD, MBA to its Board of Directors. "We are excited to welcome Matt to our Board of Directors during this important time for the… read more...

Aevi Genomic Medicine: Several Catalysts Coming In The Middle Of 2018

via: SeekingAlpha at 2017-11-29 09:39:15:000

Shares of Aevi Genomic Medicine (GNMX) rose by as much as 35% since my latest update piece towards the end of August. The stock has now swung completely around and is currently in the red by 11%. GNMX data by YCharts While pops in stock prices due solely to insider buying rarely last… read more...

A Current Look At The ROTY Contenders List

via: SeekingAlpha at 2017-11-24 23:06:21:000

ROTY (Runners of the Year) is a strategy which involves two parts, the official 10 stock model account and our Contenders List of ideas. Basically, we are looking for stocks that could outperform (ideally double or more) within the near to medium term (next quarter to 12 months out). While the… read more...

Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results

via: PR Newswire at 2017-11-02 09:27:00:000

PHILADELPHIA , Nov. 2, 2017 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the quarter ended September 30, 2017 and provided a corporate update. Third Quarter and Recent Corporate Highlights I… read more...

Can Pharma Succeed In A Condition Impacting 1 In 68 Children?

via: SeekingAlpha at 2017-10-31 04:56:22:000

About Autism In 2014, the CDC estimated that 1 in 68 children in the United States have a neurodevelopmental condition known as Autism Spectrum Disorder (or Autism). This included 1 in 42 boys (versus 1 in 189 girls). Of note, there is some regional variation, with New Jersey having a rate… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-10-20 12:39:48:000

Gainers: SKX +37% . QURE +23% . TEAM +22% . DGLY +20% . TUSK +18% . DRYS +17% . CAI +16% . XNET +14% . KALV +12% . JP +12% . More news on: Skechers USA Inc., uniQure N.V., Atlassian, Stocks on the move, Read more … read more...

ROTY Volume 1 Edition 41: Adding Selectively On Weakness

via: SeekingAlpha at 2017-10-20 07:00:00:000

Welcome to the 41st entry in our Runner of the Year (ROTY) series. Our model account utilizes a full-position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500), with cost averages calculated at the day's close. The model account is primari… read more...

Daily Insider Ratings Round Up 10/18/17: GNMX, SKY, AXDX, CONN, PWON, SXCP, CCUR

via: SeekingAlpha at 2017-10-19 18:18:51:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-10-19 12:40:04:000

Gainers: IMMY +47% . QURE +47% . ADHD +35% . GNMX +28% . PRAN +20% . RWLK +16% . SILC +16% . ZDGE +13% . CIDM +14% . RGSE +14% . More news on: Imprimis Pharmaceuticals, Inc., uniQure N.V., Alcobra Ltd., Stocks on the move, Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX